Resistant bacteria a threat to antibiotics

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 6, 2011, Pages 715-724

  Beg, Quaser Zafar ^a   Al Hazimi, Awdah Masoud ^a   Ahmed, Mohammed Qumani ^a   Fazaludeen, Mohammad Feroze ^a   Shaheen, Robina ^a  

^a UNIVERSITY OF HAIL   (Saudi Arabia)

Author keywords

Blactx M; E.coli; ESBLs; Polymerase chain reaction (PCR)

Indexed keywords

BLACTX-M; CEFTAZIDIME; E.COLI; ESBLS; LOCAL POPULATIONS; RESISTANT BACTERIA; URINE SAMPLE;

ANTIBIOTICS; GENES; HOSPITALS; PRECIPITATION (METEOROLOGY);

POLYMERASE CHAIN REACTION;

CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; DNA FRAGMENT; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLACTX M GENE; BLATEM GENE; CTX M GENE; ESCHERICHIA COLI; GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OXA GENE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SHV GENE; URINALYSIS;

EID: 84874436501     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. HM Hassan; MF Badie; RM Eisawy, J. Chem. Pharm. Res., 2011, 3(2):947-956.
2. Firdaus Jahan; Rubina Lawrence; Vinod Kumar; Mohd. Junaid, J. Chem. Pharm. Res., 2011,.3(4): 777-789.
3. S Dugal; N Mamajiwala,J. Chem. Pharm. Res., 2011, 3(1):584-589.
4. U Chaudhary, Indian journal of Medical Microbiology, 2004, 22(2): 75-80.
5. S. Nijssen, International Journal of Antimicrobial Agents, 2004,24(6): 585-591.
6. DL Paterson, Antimicrob Agents Chemother, 2003,47: 3554-60.
7. T Rajasekar; J Usharani; M. Sakthivel; B. Deivasigamani1; J. Chem. Pharm. Res., 2011,.3(5):501-513.
8. G Carmichael, The Lancet, 2004,4(8): 480.
9. CJ Munday, Journal of Antimicrobial chemotherapy, 2004, 54(3): 628-633.
10. R Bonnet, Antimicrob Agents Chemother, 2004, 48: 1-14.
11. P Bradford,Clinical Microbiol, 2001,14: 933-951.
12. DL Paterson, Clin Microbiol Rev 2005, 18: 657-686.
13. GM Rossolini, Clinical Microbiology and Infection, 2008, 14 (s1), 33-41.
14. JA Hicks, BJU International, 2007,101: 151-153.
15. C Branger,J Hosp Infect, 1997,36: 23-36.
16. J Hernendez, Antimicrob Agents Chemother, 2005,49: 2122-2125.
17. V Jarlier; MH Nicholas; G Fournier; A Philippon, Reviews of Infectious Diseases 1988, 10,.867-878.
18. RE Warren, Clinical Microbiology and Infection, 2008, 14 (s1), 124-133.
19. F Luzzaro, Journal of Clinical Microbiology, 2006, 44(5): 1659-1664.
20. R Ramphal, Clinical infectious disease, 2006, 42(suppl 4): 51-52.
21. R Cantón, Clinical Microbiology and Infection, 2008, 14 (s1), 144-153.
22. CJ Munday; VM Ensor; WE Liu; et al, Antimicrobial agents and chemoptherapy, 2002,.46: 2656-2661.
23. JPK Colom; R Alonso; AF Aranguiz; E Larino; R Cisterna,Elsevier, 2003,147-151.
24. M Quinteros; M Radice; N Gardella; et al, Antimicrobial Agents Chemotherapy, 2003, 47:.2864-7.
25. CJ Munday; J Xiong; C Li, et al, International journal of Antimicrobial agents, 2004, 23:.175-80.
26. K Yamasaki; M Komatsu; T Yamashita, et al, Journal of Antimicrobial agents and.chemotherapy, 2003, 51: 631-8.
27. WL Yu; PL Winokur; DLV Stein, Antimicrobial Agents Chemotherapy, 2002, 46: 1098-1100.
28. R Canton; A Oliver; TM Coque, et al, Journal of Clinical Microbiology, 2002, 40: 1237-43.
29. CJ Munday; M. Campbell; P.M. Hawkey et al, Journal of Antimicrobial Chemotherapy,.2004, 54: 628-633.